G Gravis Selected Research

G Gravis Research Topics

Disease

19	Neoplasms (Cancer) 02/2024 - 09/2000
11	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 04/2007
8	Renal Cell Carcinoma (Grawitz Tumor) 02/2024 - 09/2002
6	Breast Neoplasms (Breast Cancer) 12/2003 - 01/2000
3	Neoplasm Metastasis (Metastasis) 11/2015 - 11/2011
3	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 09/2014 - 03/2005
2	Carcinoma (Carcinomatosis) 02/2024 - 12/2002
2	Urinary Bladder Neoplasms (Bladder Cancer) 03/2011 - 10/2006
2	Ovarian Neoplasms (Ovarian Cancer) 07/2003 - 12/2002
1	Melanoma (Melanoma, Malignant) 02/2024
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024
1	Non-Muscle Invasive Bladder Neoplasms 01/2020
1	Residual Neoplasm 05/2019
1	Hyperalgesia 01/2015
1	Weight Loss (Weight Reduction) 01/2015
1	Peripheral Nervous System Diseases (PNS Diseases) 09/2013
1	Pain (Aches) 09/2013
1	Hypothyroidism 03/2012
1	Teratoma (Teratoid Tumor) 11/2010
1	Disease Progression 09/2008
1	Stomatitis 10/2006
1	Fatigue 10/2006
1	Dyspnea (Shortness of Breath) 10/2006
1	Transitional Cell Carcinoma 10/2006
1	Graft vs Host Disease (Graft-Versus-Host Disease) 09/2004
1	Inflammatory Breast Neoplasms 05/2004
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2003
1	Adenocarcinoma 10/2003
1	Anaphylaxis (Anaphylactic Shock) 07/2003
1	Sarcoma (Soft Tissue Sarcoma) 04/2001
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2001

Drug/Important Bio-Agent (IBA)

5	Sunitinib (Sutent)FDA Link 08/2021 - 03/2012
4	Cisplatin (Platino)FDA LinkGeneric 02/2024 - 03/2001
4	Docetaxel (Taxotere)FDA Link 01/2018 - 10/2003
3	Tyrosine Kinase InhibitorsIBA 11/2015 - 09/2008
3	Carboplatin (JM8)FDA LinkGeneric 11/2011 - 12/2002
2	avelumabIBA 08/2021 - 01/2021
2	Axitinib (AG 013736)IBA 08/2021 - 01/2021
2	Hormones (Hormone)IBA 01/2018 - 12/2003
2	AndrogensIBA 01/2018 - 10/2017
2	Ifosfamide FDA LinkGeneric 05/2014 - 09/2002
2	Gemcitabine FDA Link 05/2014 - 10/2006
2	PlatinumIBA 11/2011 - 03/2005
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2003 - 06/2002
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2002 - 06/2002
2	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2002 - 06/2002
2	Interleukin-2 (IL2)IBA 04/2001 - 09/2000
1	Immune Checkpoint InhibitorsIBA 02/2024
1	B7-H1 AntigenIBA 02/2024
1	Monoclonal AntibodiesIBA 02/2024
1	5-aminolevulinic acid hexyl ester FDA Link 05/2019
1	NivolumabIBA 11/2018
1	Abiraterone AcetateIBA 01/2018
1	antiarrhythmic peptide (AAP)IBA 01/2018
1	Prednisone (Sone)FDA LinkGeneric 01/2018
1	Prednisolone (Predate)FDA LinkGeneric 01/2018
1	Zoledronic Acid (Zometa)FDA Link 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2015
1	Analgesics (Analgesic Drugs)IBA 09/2013
1	Mitoxantrone (Novantrone)FDA LinkGeneric 09/2013
1	cabazitaxel FDA Link 09/2013
1	Thyroxine (Levothyroxine)FDA LinkGeneric 03/2012
1	Etoposide (VP 16)FDA LinkGeneric 11/2011
1	Phosphopyruvate Hydratase (Enolase)IBA 11/2011
1	Chromogranin AIBA 11/2011
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 11/2010
1	Estramustine FDA Link 01/2010
1	Prostate-Specific Antigen (Semenogelase)IBA 09/2008
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2008
1	ErbB Receptors (EGF Receptor)IBA 09/2008
1	Pemetrexed (MTA)FDA Link 10/2006
1	Transaminases (Aminotransferases)IBA 10/2006
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 09/2004
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 09/2004
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 09/2004
1	liposomal doxorubicin (Doxil)FDA Link 07/2003
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2002
1	Alkylating AgentsIBA 05/2002
1	Interferon-alpha (Interferon Alfa)IBA 03/2001
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 03/2001
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2000

Therapy/Procedure

18	Drug Therapy (Chemotherapy) 01/2020 - 01/2000
7	Therapeutics 02/2024 - 07/2003
5	Castration 01/2017 - 09/2008
4	Stem Cell Transplantation 03/2005 - 09/2000
3	Prostatectomy (Retropubic Prostatectomy) 07/2014 - 04/2007
3	Radiotherapy 04/2007 - 01/2000
2	Cystectomy 01/2023 - 03/2011
2	Adjuvant Chemotherapy 06/2002 - 01/2000
1	CARE protocol 01/2022
1	Hematopoietic Stem Cell Transplantation 09/2014
1	Salvage Therapy 09/2014
1	Neoadjuvant Therapy 03/2011
1	Lymph Node Excision (Lymph Node Dissection) 03/2011
1	Brachytherapy 04/2007
1	Blood Component Removal (Apheresis) 12/2003
1	Patient Readmission 10/2003
1	Laparotomy 12/2002
1	Immunotherapy 09/2000